The pro-proliferative effects of mortalin overexpression in cancer cells have been assigned to its binding with p53 that results in its retention in the cytoplasm, and inhibition of its normal transcriptional activation function of p5316,18–21, resulting in lifespan extension of cells, uncontrolled proliferation, and malignant transformation. The gene discussed is TP53; the disease is cancer.